This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Huperzia serrata is a traditional Chinese medicinal herb containing the alkaloid Huperzine A, which is used for the treatment of Alzheimer's disease and other cognitive impairments [PMID:31778363, PMID:14725492, PMID:28807163].
Background
Huperzia serrata, also known as Qian Ceng Ta, is a member of the Lycopodiaceae family [PMID:38697240, PMID:19938535]. It is an endangered species due to overexploitation [PMID:31346505, PMID:34072855].
Traditional uses
Traditionally used in Chinese medicine for treating rheumatic numbness, arthritic pain, dysmenorrhea, contusions, strains, swellings, schizophrenia, myasthenia gravis, and organophosphate poisoning [PMID:38697240, PMID:17644292, PMID:19938535].
Active compounds
The plant contains lycopodium alkaloids, most notably Huperzine A [PMID:31351127, PMID:14725492]. Other identified compounds include huperradines A-K, hupertimines A-E, serratane-type triterpenoids, phenolic acids (caffeic acid and ferulic acid), flavonoids, and polysaccharides [PMID:38697240, PMID:35604198, PMID:15248614, PMID:34526893, PMID:39571762].
Mechanism of action
Huperzine A acts as a potent, selective, and slow reversible inhibitor of acetylcholinesterase (AChE) [PMID:14725492, PMID:19240260, PMID:18565502]. It may also exert neuroprotective effects by interacting with alpha-7 and alpha-4-beta-2 nicotinic acetylcholine receptors, suppressing NF-kappaB signaling, and reducing pro-inflammatory cytokines like IL-1beta and TNF-alpha [PMID:27086593, PMID:34770940].
Clinical evidence
Evidence CAlzheimer's Disease
Huperzine A has shown promising effects on cognitive functions, improvement in activities of daily living, and neuropsychiatric symptoms in clinical trials [PMID:28807163, PMID:35384262].
Evidence CVascular Dementia
Huperzine A has been proven to significantly improve learning and memory impairment in patients [PMID:18565502].
Safety & adverse effects
Huperzine A is described as well-tolerated [PMID:18565502], although some chemical drugs for Alzheimer's are noted to have significant adverse reactions [PMID:31778363].
Evidence summary
Evidence is primarily based on reviews and preclinical studies (Level C and D), with mentions of Phase II and III clinical trials for Huperzine A in the treatment of Alzheimer's disease.
PubMed sources
1.PMID: 31778363 (2019) — The use of Huperzia species for the treatment of Alzheimer's disease. · Journal of basic and clinical physiology and pharmacology
4.PMID: 34419561 (2021) — Secondary metabolites of endophytic fungi isolated from Huperzia serrata. · Fitoterapia
5.PMID: 28807163 (2017) — Effect of Chinese Herbal Medicine on Alzheimer's Disease. · International review of neurobiology
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
PMID: 35384262 (2022) — Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease. · IUBMB life
7.PMID: 21791295 (2011) — Traditional Chinese medicines and Alzheimer's disease. · Taiwanese journal of obstetrics & gynecology
8.PMID: 38697240 (2024) — Lycopodium alkaloids from Huperzia serrata and their cholinesterase inhibitory activities. · Phytochemistry
9.PMID: 31376517 (2019) — Ethnopharmacology of the club moss subfamily Huperzioideae (Lycopodiaceae, Lycopodiophyta): A phylogenetic and chemosystematic perspective. · Journal of ethnopharmacology
10.PMID: 15248614 (2004) — Serratane-type triterpenoids from Huperzia serrata. · Natural product research
12.PMID: 37507844 (2023) — Lycopodium Alkaloids from Huperzia serrata and Their Anti-acetylcholinesterase Activities. · Chemistry & biodiversity
13.PMID: 17644292 (2007) — Huperzine A from Huperzia species--an ethnopharmacolgical review. · Journal of ethnopharmacology
14.PMID: 40689330 (2025) — A perspective on the mechanisms of herbal medicine for cognitive impairment. · Frontiers in neurology
15.PMID: 19240260 (2009) — Role of huperzine a in the treatment of Alzheimer's disease. · The Annals of pharmacotherapy
16.PMID: 27086593 (2016) — Huperzine A as a neuroprotective and antiepileptic drug: a review of preclinical research. · Expert review of neurotherapeutics
17.PMID: 39571762 (2025) — Pharmacology, phytochemistry, and traditional uses of Huperzia serrata (Thunb. ex Murray) Trev. · Fitoterapia
18.PMID: 34526893 (2021) — Huperzia serrata Extract 'NSP01' With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols. · Frontiers in pharmacology
19.PMID: 34770940 (2021) — Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease. · Molecules (Basel, Switzerland)
20.PMID: 18565502 (2008) — Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. · Chemico-biological interactions
21.PMID: 31346505 (2019) — Development of polymorphic simple sequence repeat markers in Huperzia serrata (Lycopodiaceae). · Applications in plant sciences
22.PMID: 34072855 (2021) — In Vitro Propagation, Huperzine A Content and Antioxidant Activity of Three Genotypic Huperzia serrata. · Plants (Basel, Switzerland)
23.PMID: 19938535 (2009) — [Research advances of Huperzia serrata (Thunb.) Trev]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica